Abayon, Romeo L.
HRN: 22-11-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/24/2022
10/31/2022
IVT
500mg
Q8hours
Indirect Hernia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes